欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DE/H/0498/001
药品名称
Xafenor 145 mg Filmtablette
活性成分
fenofibrate 145.0 mg
剂型
Film-coated tablet
上市许可持有人
Viatris Healthcare GmbH Lütticher Straße 5 53842 Troisdorf Germany
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Portugal (PT)
许可日期
2005/04/05
最近更新日期
2024/08/09
药物ATC编码
C10AB05 fenofibrate
申请类型
TypeLevel1：
Line Extension
TypeLevel2：
Initial Application
TypeLevel3：
Full Dossier [Article 8.3(i)]
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Product Information
|
common_final_pl_0498_V053
Date of last change:2024/09/06
Final Product Information
|
common_final_spc_0498_V053
Date of last change:2024/09/06
Final PL
|
common_pl_annotated_fenofibrate 145 mg_WS_Feb 2017final
Date of last change:2024/09/06
Final PL
|
common_pl_annotated_fenofibrate 160 mg_WS_Feb 2017final
Date of last change:2024/09/06
Final PL
|
common_pl_annotated_fenofibrate 200mg_WS_Feb 2017final
Date of last change:2024/09/06
Final PL
|
common_pl_annotated_fenofibrate 215 mg_WS_Feb 2017final
Date of last change:2024/09/06
Final PL
|
common_pl_annotated_fenofibrate 67mg_WS_Feb 2017final
Date of last change:2024/09/06
Final PL
|
common_pl_clean_fenofibrate 145 mg_WS_Feb 2017final
Date of last change:2024/09/06
Final PL
|
common_pl_clean_fenofibrate 160 mg_WS_Feb 2017final
Date of last change:2024/09/06
Final PL
|
common_pl_clean_fenofibrate 200mg_WS_Feb 2017final
Date of last change:2024/09/06
Final PL
|
common_pl_clean_fenofibrate 215 mg_WS_Feb 2017final
Date of last change:2024/09/06
Final PL
|
common_pl_clean_fenofibrate 67mg_WS_Feb 2017final
Date of last change:2024/09/06
Final SPC
|
common_spc_annotated_feno 145 mg_WS_Feb 2017final
Date of last change:2024/09/06
Final SPC
|
common_spc_annotated_fenofibrate 200mg_WS_Feb 2017final
Date of last change:2024/09/06
Final SPC
|
common_spc_annotated_fenofibrate 215 mg_WS_Feb 2017final
Date of last change:2024/09/06
Final SPC
|
common_spc_annotated_fenofibrate 67mg_WS_Feb 2017final
Date of last change:2024/09/06
Final SPC
|
common_spc_annotated_fenofibrate_160mg_WS_Feb 2017final
Date of last change:2024/09/06
Final SPC
|
common_spc_clean_fenofibrate 145 mg_WS_Feb 2017final
Date of last change:2024/09/06
Final SPC
|
common_spc_clean_fenofibrate 200mg_WS_Feb 2017final
Date of last change:2024/09/06
Final SPC
|
common_spc_clean_fenofibrate 215 mg_ WS_ Feb 2017final
Date of last change:2024/09/06
Final SPC
|
common_spc_clean_fenofibrate 67mg_WS_Feb 2017final
Date of last change:2024/09/06
Final SPC
|
common_spc_clean_fenofibrate_160mg_WS_Feb 2017final
Date of last change:2024/09/06
Final PL
|
pl_fenofibrate all strengths_annotated_WS_Feb 2017final
Date of last change:2024/09/06
Final PL
|
pl_fenofibrate all strengths_clean_WS_Feb 2017final
Date of last change:2024/09/06
Final SPC
|
spc_feno all strengths_annotated_WS_Feb 2017final
Date of last change:2024/09/06
Final SPC
|
spc_fenofibrate all strengths_clean_WS_Feb 2017final
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase